|
US4838925A
(en)
|
1986-04-25 |
1989-06-13 |
E. I. Du Pont De Nemours And Company |
Heterocyclic acyl sulfonamides
|
|
JP3763997B2
(ja)
|
1999-05-13 |
2006-04-05 |
富士写真フイルム株式会社 |
感熱記録材料
|
|
JP4331823B2
(ja)
|
1999-05-21 |
2009-09-16 |
富士フイルム株式会社 |
ピロロ［１，２−ａ］−１，３，５−トリアジン−４−オン系化合物
|
|
SK9742002A3
(en)
|
2000-01-07 |
2003-02-04 |
Transform Pharmaceuticals Inc |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
JP4070966B2
(ja)
|
2001-06-28 |
2008-04-02 |
株式会社カネボウ化粧品 |
新規ガラクトシルセラミド類縁体及び用途
|
|
ATE307812T1
(de)
|
2001-10-22 |
2005-11-15 |
Pfizer |
Imidazopyridinverbindungen als 5-ht4- rezeptormodulatoren
|
|
CA2476757A1
(en)
|
2002-03-01 |
2003-09-12 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound
|
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
|
AU2003259482A1
(en)
|
2002-09-20 |
2004-04-08 |
Pfizer Japan Inc. |
N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators
|
|
WO2004052315A2
(en)
|
2002-12-11 |
2004-06-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
JP2004277337A
(ja)
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
EP1620435A1
(en)
|
2003-04-21 |
2006-02-01 |
Pfizer Inc. |
IMADAZOPYRIDINE COMPOUNDS HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY AND 5-HT sb 3 /sb RECEPTOR ANTAGONISTIC ACTIVITY
|
|
CN1906162B
(zh)
|
2003-11-12 |
2012-05-23 |
阿米库斯治疗学公司 |
用于治疗戈谢病的羟基哌啶衍生物
|
|
GB0329214D0
(en)
*
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
CA2556404A1
(en)
|
2004-02-18 |
2005-08-25 |
Banyu Pharmaceutical Co., Ltd. |
Nitrogenous fused heteroaromatic ring derivative
|
|
US8318724B2
(en)
|
2004-05-14 |
2012-11-27 |
The Cleveland Clinic Foundation |
Small molecule inhibitors of MRP1 and other multidrug transporters
|
|
CA2571487C
(en)
|
2004-06-21 |
2013-04-30 |
F. Hoffmann-La Roche Ag |
Pyrrazolo-pyrimidine derivatives
|
|
ATE390424T1
(de)
|
2004-08-02 |
2008-04-15 |
Sanol Arznei Schwarz Gmbh |
Carboxamide des indolizins und seiner aza- und diazaderivate
|
|
DE102004049363A1
(de)
|
2004-10-08 |
2006-04-13 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
WO2006078676A2
(en)
|
2005-01-19 |
2006-07-27 |
Merck & Co., Inc. |
Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
WO2006084634A1
(en)
|
2005-02-11 |
2006-08-17 |
F.Hoffmann-La Roche Ag |
Pyrazolo-pyrimidine derivatives as mglur2 antagonists
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
CA2605351A1
(en)
|
2005-04-21 |
2006-11-02 |
Dainippon Sumitomo Pharma Co., Ltd. |
N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same
|
|
JP5079500B2
(ja)
|
2005-04-28 |
2012-11-21 |
協和発酵キリン株式会社 |
２−アミノキナゾリン誘導体
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
AR057979A1
(es)
|
2005-10-06 |
2008-01-09 |
Schering Corp |
PIRAZOLPIRIMIDINAS COMO INHIBIDORAS DE PROTEíNA QUINASA. COMPOSICIONES FARMACEUTICAS.
|
|
CA2626742A1
(en)
|
2005-10-21 |
2007-04-26 |
Exelixis, Inc. |
Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
|
|
BRPI0619517A2
(pt)
|
2005-12-08 |
2011-10-04 |
Novartis Ag |
ácidos pirazolo[1,5-a]piridina-3-carboxìlicos como inibidores de ephb e vegfr2 cinase
|
|
TW200800997A
(en)
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
KR101402554B1
(ko)
|
2006-06-23 |
2014-06-19 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
β-글루코세레브로시다제의 활성 증진에 의한 신경계 장애 치료 방법
|
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
|
WO2008019363A2
(en)
|
2006-08-07 |
2008-02-14 |
Albany Molecular Research, Inc. |
2-alkylbenzoxazole carboxamides as 5ht3 modulators
|
|
AU2007321922A1
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic matrix metalloprotease inhibitors
|
|
WO2008063671A2
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
CN101801972A
(zh)
|
2007-03-28 |
2010-08-11 |
英诺瓦西亚公司 |
作为硬脂酰-辅酶a去饱和酶抑制剂的吡唑并[1,5-a]嘧啶
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
US20110053932A1
(en)
|
2007-06-21 |
2011-03-03 |
Irm Llc |
Protein Kinase Inhibitors and Methods for Using Thereof
|
|
WO2009060835A1
(ja)
|
2007-11-05 |
2009-05-14 |
Kyoto University |
新規ユビキリン結合性小分子
|
|
WO2009060197A1
(en)
|
2007-11-08 |
2009-05-14 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazopyridazines for use as protein kinase inhibitors
|
|
JP2011504931A
(ja)
|
2007-11-28 |
2011-02-17 |
シェーリング コーポレイション |
プロテインキナーゼ阻害剤としての２−フルオロピラゾロ［１，５−ａ］ピリミジン
|
|
CN101981033B
(zh)
|
2008-02-06 |
2015-02-04 |
百时美施贵宝公司 |
用作激酶抑制剂的取代的咪唑并哒嗪化合物
|
|
JPWO2009119088A1
(ja)
|
2008-03-25 |
2011-07-21 |
武田薬品工業株式会社 |
複素環化合物
|
|
CA2723135A1
(en)
|
2008-05-01 |
2009-11-05 |
Sirtris Pharmaceuticals, Inc. |
Quenolines and related analogs as sirtuin modulators
|
|
ES2565611T3
(es)
|
2008-10-14 |
2016-04-05 |
Entasis Therapeutics Limited |
Compuestos heteroaromáticos espirocíclicos y condensados para el tratamiento de infecciones bacterianas
|
|
CN102271515B
(zh)
*
|
2008-10-31 |
2014-07-02 |
健泰科生物技术公司 |
吡唑并嘧啶jak抑制剂化合物和方法
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
DK2467141T3
(en)
|
2009-08-17 |
2019-02-18 |
Intellikine Llc |
HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
|
|
WO2012007375A1
(en)
*
|
2010-07-13 |
2012-01-19 |
F. Hoffmann-La Roche Ag |
Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
TW201217312A
(en)
|
2010-09-22 |
2012-05-01 |
Gruenenthal Gmbh |
Substituted benzamide compounds
|
|
WO2012075393A2
(en)
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
|
SI2649075T1
(sl)
|
2010-12-08 |
2018-10-30 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Substituirani pirazolopirimidini kot aktivatorji glukocerebrozidaze
|
|
EP2678016B1
(en)
|
2011-02-23 |
2016-08-10 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
|
US9169260B2
(en)
*
|
2011-03-22 |
2015-10-27 |
Merck Sharp & Dohme Corp. |
Amidopyrazole inhibitors of interleukin receptor-associated kinases
|
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
KR101778354B1
(ko)
|
2011-08-18 |
2017-09-13 |
니뽄 신야쿠 가부시키가이샤 |
헤테로환 유도체 및 의약
|
|
BR112014005110A2
(pt)
|
2011-09-02 |
2017-04-18 |
Bayer Ip Gmbh |
pirimidinas aneladas substituídas e utilização das mesmas
|
|
WO2013059119A1
(en)
|
2011-10-17 |
2013-04-25 |
The Regents Of The University Of Michigan |
Glucosylceramide synthase inhibitors and therapeutic methods using the same
|
|
KR20140077963A
(ko)
|
2011-10-20 |
2014-06-24 |
글락소스미스클라인 엘엘씨 |
시르투인 조절제로서의 치환된 비시클릭 아자-헤테로사이클 및 유사체
|
|
EA201491260A1
(ru)
|
2011-12-23 |
2014-11-28 |
Новартис Аг |
Соединения и композиции для ингибирования взаимодействия bcl2 с партнерами по связыванию
|
|
US9340549B2
(en)
*
|
2012-03-05 |
2016-05-17 |
Amgen Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
EP2822559B1
(en)
|
2012-03-09 |
2018-05-02 |
Lexicon Pharmaceuticals, Inc. |
Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and uses thereof
|
|
CN104220071A
(zh)
|
2012-03-09 |
2014-12-17 |
莱西肯医药有限公司 |
抑制转接物关联激酶1以治疗疼痛
|
|
JP2015512913A
(ja)
|
2012-03-28 |
2015-04-30 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
グルコセレブロシダーゼ活性剤として有用なサリチル酸誘導体
|
|
CA2870407A1
(en)
|
2012-05-31 |
2013-12-05 |
F. Hoffmann-La Roche Ag |
Aminoquinazoline and pyridopyrimidine derivatives
|
|
EP2865671B1
(en)
|
2012-06-22 |
2017-11-01 |
Sumitomo Chemical Company, Ltd |
Fused heterocyclic compound
|
|
WO2014025651A1
(en)
|
2012-08-06 |
2014-02-13 |
Amgen Inc. |
Chroman derivatives as trpm8 inhibitors
|
|
US20150216168A1
(en)
|
2012-09-05 |
2015-08-06 |
Bayer Cropscience Ag |
Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
|
|
EP2920181B1
(en)
|
2012-11-16 |
2019-01-09 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
EP2925750A1
(en)
|
2012-11-29 |
2015-10-07 |
Karyopharm Therapeutics, Inc. |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
|
|
FI4190786T3
(fi)
*
|
2012-12-07 |
2025-05-23 |
Vertex Pharma |
Atr-kinaasin estäjinä käyttökelpoisia yhdisteitä
|
|
KR20140086002A
(ko)
|
2012-12-28 |
2014-07-08 |
한미약품 주식회사 |
Fms 키나아제 저해 활성을 갖는 피리다진 접합고리 유도체
|
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
WO2014144455A1
(en)
|
2013-03-15 |
2014-09-18 |
Epizyme, Inc. |
1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
WO2015012328A1
(ja)
|
2013-07-24 |
2015-01-29 |
武田薬品工業株式会社 |
複素環化合物
|
|
WO2015026574A1
(en)
|
2013-08-20 |
2015-02-26 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
|
CN105658653A
(zh)
|
2013-08-23 |
2016-06-08 |
因赛特公司 |
可用作pim激酶抑制剂的呋喃并-和噻吩并-吡啶甲酰胺化合物
|
|
AR097543A1
(es)
|
2013-09-06 |
2016-03-23 |
Lexicon Pharmaceuticals Inc |
COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
|
|
TW201542550A
(zh)
|
2013-09-06 |
2015-11-16 |
Lexicon Pharmaceuticals Inc |
吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
|
|
WO2015073267A1
(en)
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
ES2895490T3
(es)
|
2014-03-27 |
2022-02-21 |
Acad Medisch Ct |
Iminoazúcares N-(5-(bifen-4-ilmetiloxi)pentil)-sustituidos como inhibidores de glucosilceramida sintasa
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
KR102662215B1
(ko)
|
2014-11-06 |
2024-05-02 |
비알 - 알&디 인베스트먼츠, 에스.에이. |
치환된 피라졸로(1,5-a)피리미딘 및 의학적 장애의 치료에서의 그의 용도
|
|
EP3215509B1
(en)
|
2014-11-06 |
2020-02-26 |
Lysosomal Therapeutics Inc. |
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
|
|
US20170333435A1
(en)
|
2014-11-06 |
2017-11-23 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
|
|
US10167270B2
(en)
|
2015-07-01 |
2019-01-01 |
Northwestern University |
Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity
|
|
CN108290894A
(zh)
|
2015-07-01 |
2018-07-17 |
西北大学 |
被取代的4-甲基-吡咯并[1,2-a]嘧啶-8-甲酰胺类化合物及其调节葡糖脑苷脂酶活性的用途
|
|
WO2017040877A1
(en)
|
2015-09-04 |
2017-03-09 |
Lysosomal Therapeutics Inc. |
Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
|
|
LT3371190T
(lt)
|
2015-11-06 |
2022-08-10 |
Incyte Corporation |
Heterocikliniai junginiai, kaip pi3k-gama inhibitoriai
|
|
WO2017087590A1
(en)
|
2015-11-18 |
2017-05-26 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
|
|
WO2017140825A1
(en)
|
2016-02-18 |
2017-08-24 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds, compositions and methods of use thereof
|
|
BR112018070586A8
(pt)
|
2016-04-06 |
2023-03-14 |
Lysosomal Therapeutics Inc |
Compostos de pirazol[1,5-a]pirimidinil carboxamida e seu uso no tratamento de distúrbios médicos
|
|
WO2017176962A1
(en)
|
2016-04-06 |
2017-10-12 |
Lysosomal Therapeutics, Inc. |
Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
JP7046827B2
(ja)
|
2016-04-06 |
2022-04-04 |
リソソーマル・セラピューティクス・インコーポレイテッド |
イミダゾ［１，５－ａ］ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用
|
|
WO2017192841A1
(en)
|
2016-05-04 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
US20190389865A1
(en)
|
2016-05-05 |
2019-12-26 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED PYRROLO[1,2-a]TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
US11345698B2
(en)
|
2016-05-05 |
2022-05-31 |
Bial—R&D Investments, S.A. |
Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders
|
|
CN109311902B
(zh)
|
2016-05-05 |
2022-07-15 |
Bial研发投资股份有限公司 |
取代的咪唑并[1,2-b]哒嗪、咪唑并[1,5-b]哒嗪、相关化合物及其用途
|
|
EP3728265A1
(en)
|
2017-12-21 |
2020-10-28 |
BIAL - BioTech Investments, Inc. |
Crystalline substituted cyclohexyl pyrazolo[1,5-a]pyrimidinyl carboxamide compound and therapeutic uses thereof
|